Personalized Nutrition Companies’ Claims Overhyped: Scientists
Personalized Nutrition Companies’ Claims Overhyped: Scientists
Services promising scientifically tailored supplements or advice abound. Experts say their claims are largely unfounded, although some solid evidence is beginning to emerge.
Personalized Nutrition Companies’ Claims Overhyped: Scientists
Personalized Nutrition Companies’ Claims Overhyped: Scientists

Services promising scientifically tailored supplements or advice abound. Experts say their claims are largely unfounded, although some solid evidence is beginning to emerge.

Services promising scientifically tailored supplements or advice abound. Experts say their claims are largely unfounded, although some solid evidence is beginning to emerge.

dtc
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Shawna Williams | Mar 28, 2018
An analysis of 49 patient samples finds high proportions of false positives and misinterpretation.
Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
Opinion: Get to Know Why People Openly Share Genomic Data
Opinion: Get to Know Why People Openly Share Genomic Data
Tobias Haeusermann | May 9, 2017
It’s not only about health but also about exploring ancestry and contributing to science.